| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NVS
|
581.00 | 1.8B | 1.73 | 0.73 | 0.57 | 14.5% | 20.3% | 75 | 39 | 1,420.61 | +104.1% | 84 | 0.15 |
|
KAL
|
5,162.00 | 3.5B | 1.82 | 0.99 | 1.73 | 9.3% | 15.6% | 73 | 36 | 9,464.72 | +60.0% | 64 | 0.69 |
|
ADH
|
4,884.00 | 26.6B | 4.82 | 3.96 | 2.83 | 19.1% | 18.5% | 49 | 33 | 3,542.99 | -19.8% | 72 | 0.31 |
|
SDO
|
1,288.00 | 10.9B | 8.29 | 5.25 | 5.45 | 16.6% | 19.1% | 39 | 29 | 585.94 | -40.9% | 84 | 0.12 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.